Entos Pharmaceuticals

We are at #PODD2024 in Boston - Day 2! Our CEO John Lewis is in a panel discussion about Vaccine Delivery Innovations as part of Track 3 Novel Modalities. DM the Entos team, John Lewis, Jason Ding, FCPA, FCA, or Jailal Ablack to connect at the conference! #Fusogenix #PLV #vaccinedelivery #precisionmedicine #advancedmedicines

Today is Day 1 of #PODD2024 in Boston! Are you attending? Don't miss John Lewis' presentation today at 2:30 pm in Track 4A: Cell & Gene Delivery and tomorrow' Vaccine Delivery Innovations panel chat at 4:05 pm in Track 3 Novel Modalities. More info below. DM John Lewis, Jason Ding, FCPA, FCA, or Jailal Ablack to connect at the conference.

Oct 23, 2024 - CEO John Lewis was on CBC/Radio-Canada Radio Active with Jessica Ng, and Min Dhariwal talking about a big breakthrough in advanced therapeutics from the Lewis lab at the University of Alberta, Duncan lab at Dalhousie University, and Entos Pharmaceuticals. Go to https://lnkd.in/gvpa3-Gz to listen! #Fusogenix #PLV #advancedtherapeutics

ICYMI! On October 22, 2024, Sarah Ryan from Global News Hour at 6 Edmonton reported findings from John Lewis' lab at the University of Alberta, Roy Duncan's lab at Dalhousie University, and Entos Pharmaceuticals "Medical breakthrough could one day cure deadly cancers." This study was highlighted in the University of Alberta's Folio magazine on October 23 and published in the journal Cell by Cell Press on September 10. Read more here: https://lnkd.in/ggm2HHcH https://lnkd.in/gn6HduB7 #advancedtherapeutics #Fusogenix #PLV

I'm absolutely thrilled to announce that I'll be appearing as a featured speaker at the much-anticipated BioProcess International US West 2025 conference. I will be shedding light on our work regarding the production of ProteoLipid Vehicles (PLVs) for vaccine application. This topic is of prime significance in today's health landscape, and we're enthusiastic to share our journey and findings. Our state-of-the-art facility in Carlsbad is fully equipped to handle GMP production of nanoparticles. We take pride in maintaining stringent production procedures, ensuring each nanoparticle batch meets specific industry standards. Looking forward to engaging discussions and knowledge exchange at the conference! Join me on-site and save 30% off your pass by clicking here https://lnkd.in/gfGhU95t Informa Connect

The University of Alberta highlighted research stemming from John Lewis' lab in the Faculty of Medicine & Dentistry, University of Alberta and collaborator Roy Duncan's lab from Dalhousie University that was recently published in the journal Cell by Cell Press. Read the story in today's Folio magazine by Michael Brown! U of A-led team overcomes a circulatory roadblock that has prevented gene therapies from reaching their intended targets. https://lnkd.in/gBDm2k_2 #Fusogenix #PLV #advancedtherapeutics Arun Raturi Jason Ding, FCPA, FCA Steve C. Douglas Brown

Behold changing leaves, cooler weather, and exciting scientific discoveries published in the latest Canada in Science from Mena Abdel-Nour: https://bit.ly/3Yv3IGq

The LES USA-Canada Annual Meeting is in full swing in New Orleans! From 11:20 to 12:20 pm today Jason Ding, FCPA, FCA will be a panelist in the Life Sciences Spinouts from In-License to Exit workshop, along with Gayatri Varma and James Zanewicz, JD, LLM, RTTP, and moderator Adam Falconi. This promises to be a great discussion! For the full meeting program go to https://lnkd.in/dUxF5YRv Licensing Executives Society (U.S.A. and Canada), Inc. #LESAM024 Entos Pharmaceuticals Mintz

Entos will be at #PODD2024 on October 28 to 29 in Boston! CEO John Lewis and CBO Jason Ding, FCPA, FCA will join the best and brightest in drug delivery to meet and discuss emerging technologies like Entos Pharmaceuticals' Fusogenix PLV drug delivery platform. Will you be there? DM to set up a meeting with John Lewis and Jason Ding, FCPA, FCA, either before, during, or after the conference to learn more about our drug delivery tech. Don't miss these two sessions: October 28: Track 4A: Cell & Gene Delivery at 2:30 - 2:45 PM John Lewis presenting: Delivering on the Promise of Genetic Medicines: Safe and Effective In Vivo Delivery of Nucleic Acids with the Fusogenix PLV Platform. October 29: Track 3: Novel Modalities at 4:05 PM - 4:35 PM Vaccine Delivery Innovations Panel Panelists: Anthony Barry, PhD, Executive Director, and ES&I Lead: Biotherapeutics, Technologies, and Digital at Pfizer John Lewis, PhD, CEO at Entos Pharmaceuticals Namal Nawana, BEng, MMedSc, MBA, Executive Chairman & Founder at SatioRX Derek O'Hagan, Senior Advisor Vaccines R&D at GSK PODD: Partnership Opportunities in Drug Delivery Community News #PODD24 #Fusogenix #PLV

Day 1 of the Formulation & Delivery US 2024 conference. The Entos Pharmaceuticals team Ping Wee, Maya Holay, Ph.D., Jitendra Kumar, Silke Andresen, Ritu Raturi, and Alex Sevy are there! Go check out our poster "Gene Therapy Using the Fusogenix Proteolipid Vehicle (PLV) Platform" and DM to connect to continue the conversation! Formulation & Delivery by Oxford Global #DrugDevelopment #DrugDelivery #FormulationSciences #Fusogenix #PLV